(Q36859841)

English

Effects of mirodenafil, a phosphodiesterase-5 inhibitor, on female rat bladder in a partial bladder outlet obstruction model: physiological and immunohistochemical aspects

scientific article published on 14 May 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Effects of mirodenafil, a phosphodiesterase-5 inhibitor, on female rat bladder in a partial bladder outlet obstruction model: physiological and immunohistochemical aspects (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

author name string

Jung Yoon Kang

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Eun Kyung Kim

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Kwang Myung Kim

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

14 May 2013

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Korean Journal of Urology

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

54

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

339-344

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

1 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659229

29 September 2017

Changes of bladder activity and connexin 43-derived gap junctions after partial bladder-outlet obstruction in rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659229

29 September 2017

Role of gap junctions in spontaneous activity of the rat bladder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659229

29 September 2017

Origin of spontaneous activity in neonatal and adult rat bladders and its enhancement by stretch and muscarinic agonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659229

29 September 2017

A randomized, placebo-controlled study to assess safety and efficacy of vardenafil 10 mg and tamsulosin 0.4 mg vs. tamsulosin 0.4 mg alone in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659229

4 September 2018

Suppression of detrusor overactivity in rats with bladder outlet obstruction by a type 4 phosphodiesterase inhibitor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659229

4 September 2018

Identification and functional study of phosphodiesterases in rat urinary bladder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659229

4 September 2018

Vardenafil Improves Urodynamic Parameters in Men With Spinal Cord Injury: Results From a Single Dose, Pilot Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659229

4 December 2018

Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/23700501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23700501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased expression of connexin 43 in the overactive neurogenic detrusor

1 reference

https://pubmed.ncbi.nlm.nih.gov/23700501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gap junctions and connexin expression in human suburothelial interstitial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23700501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in contractile properties in hypertrophic rat urinary bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/23700501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4111/KJU.2013.54.5.339

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36859841&oldid=2166082287"